JamesNIngleMD

Clinical Trials

• Hormone Therapy in Treating Postmenopausal Women With Receptor-Positive Breast Cancer Start of enrollment: 1995 Oct 01

  Completed

  Phase 3

• Marimastat or No Further Therapy in Treating Women With Metastatic Breast Cancer That Is Responding or Stable Following Chemotherapy Start of enrollment: 1997 Dec 02

  Completed

  Phase 3

• Combination Chemotherapy in Treating Patients With Breast Cancer Start of enrollment: 1997 Sep 01

  Completed

  Phase 3

• Letrozole After Tamoxifen in Treating Women With Breast Cancer Start of enrollment: 1998 Aug 24

  Completed

  Phase 3

• ICI 182780 in Treating Women With Metastatic Breast Cancer Start of enrollment: 2001 May 01

  Completed

  Phase 2

• Exemestane or Anastrozole in Treating Postmenopausal Women Who Have Undergone Surgery for Primary Breast Cancer Start of enrollment: 2003 Jun 06

  Completed

  Phase 3

• Suppression of Ovarian Function With Either Tamoxifen or Exemestane Compared With Tamoxifen Alone in Treating Premenopausal Women With Hormone-Responsive Breast Cancer Start of enrollment: 2003 Dec 17

  Active, not recruiting

  Phase 3

• Temozolomide and Radiation Therapy in Treating Patients With Stage IV Malignant Melanoma With Measurable and Unresectable Cancer of the Central Nervous System Start of enrollment: 2004 Jan 01

  Terminated

  Phase 2

• Everolimus in Treating Patients With Stage IV Melanoma Start of enrollment: 2005 Apr 01

  Completed

  Phase 2

• S0307 Phase III Trial of Bisphosphonates as Adjuvant Therapy for Primary Breast Cancer. Start of enrollment: 2005 Jul 01

  Completed

  Phase 3

• Three Doses of TAS-108 to Treat Recurrent or Recurrent Inoperable Breast Cancer Start of enrollment: 2004 May 01

  Completed

  Phase 2

• Pharmacogenetics of Anastrozole in Postmenopausal Women With Estrogen Receptor-Positive and/or Progesterone Receptor-Positive Stage I, Stage II, or Stage III Breast Cancer Start of enrollment: 2005 Jul 01

  Completed

• Breast Density, Hormone Levels, and Anticancer Drug Levels in Women With Invasive Breast Cancer Who Are Receiving Exemestane or Anastrozole Start of enrollment: 2006 Apr 01

  Completed

• Bone Mineral Density in Postmenopausal Women With Primary Breast Cancer Who Are Receiving Treatment on Clinical Trial Start of enrollment: 2006 Apr 24

  Completed

  Phase 3

• Doxorubicin and Cyclophosphamide Followed By Trastuzumab, Paclitaxel, and Lapatinib in Treating Patients With Early-Stage HER2-Positive Breast Cancer That Has Been Removed By Surgery Start of enrollment: 2007 Mar 16

  Completed

  Phase 2

• Changes in Breast Density and Blood Hormone Levels in Postmenopausal Women Receiving Anastrozole or Exemestane for Breast Cancer Start of enrollment: 2007 Sep 01

  Completed

• Safety and Efficacy Comparison of Docetaxel and Ixabepilone in Non Metastatic Poor Prognosis Breast Cancer Start of enrollment: 2007 Sep 01

  Completed

  Phase 3

• Epirubicin, Docetaxel, and Capecitabine in Treating Women With Stage IIIA or Stage IIIB Breast Cancer Start of enrollment: 2003 Apr 01

  Completed

  Phase 2

• SWOG-8814 Tamoxifen With or Without Combination Chemotherapy in Postmenopausal Women Who Have Undergone Surgery for Breast Cancer Start of enrollment: 1989 May 01

  Completed

  Phase 3

• Study of Blood Samples From High-Risk Postmenopausal Women Who Received Treatment on Breast Cancer Prevention Clinical Trials NSABP-P-1 or NSABP-P-2 Start of enrollment: 2009 Apr 01

  Unknown status

• Study of Tumor and Blood Samples From Postmenopausal Women With Primary Breast Cancer Enrolled on Clinical Trial CAN-NCIC-MA27 Start of enrollment: 2008 Sep 01

  Completed

• Join now to see all